FORMA Therapeutics Announces Upcoming Presentations at the 31st Annual Piper Jaffray Healthcare Conference and the 2019 ASH Annual Meeting

Tags:   ASH  

WATERTOWN, Mass.--(BUSINESS WIRE)--FORMA Therapeutics Inc., a clinical stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced that the company will present at two meetings in December:

About FORMA

FORMA Therapeutics is focused on the discovery, development and commercialization of transformative medicines for patients with rare hematologic diseases and cancers. A fully-integrated biopharmaceutical company, FORMA’s validated, proprietary RandD engine combines deep biology insight, chemistry expertise and clinical development capabilities to create differentiated drug candidates with best-in-class or first-in-class potential. FORMA has delivered high-value clinical candidates to its partners and generated a broad proprietary portfolio of programs, ranging from preclinical to pivotal-stage, with the potential to provide profound patient benefit. For more information, please visit the company website at www.formatherapeutics.com or follow us on Twitter @FORMAInc and LinkedIn.

---

---

Contacts

Investor Contact: Stephanie Ascher, +1 212-362-1200 Stern Investor Relations stephanie.ascher@sternir.com Media Contact: Kari Watson, +1 781-235-3060 MacDougall kwatson@macbiocom.com

Investor Contact: Stephanie Ascher, +1 212-362-1200 Stern Investor Relations stephanie.ascher@sternir.com Media Contact: Kari Watson, +1 781-235-3060 MacDougall kwatson@macbiocom.com